Navigation Links
Investor Group Commends Jim Merselis for Joining Trinity Biotech's Board of Directors & Announces Conference Call Invitation
Date:2/12/2009

KANSAS CITY, Mo., Feb. 12 /PRNewswire/ -- An investor group in Trinity Biotech plc (Nasdaq: TRIB), an Irish based developer and manufacturer of diagnostic products, is delighted that Jim Merselis has joined the company's board of directors. In addition to expressing support for Mr. Merselis, the group has scheduled a conference call regarding important shareholder developments for 12:00 pm ET (9:00 am PT) on Tuesday, February 17, 2009.

All those interested in participating in the call should dial 888 300 5688 and reference Conference ID 85881585.

Commenting on the news, Mr. Reidy stated, "We are pleased Jim has agreed to serve, bringing the total of independent directors to two. While Jim's agreement to join as part of our broader effort is honorable, we continue our call to action for true board oversight and management accountability. We look forward to Jim remaining as part of our new board immediately following the pending action to remove and replace the current board."

Commenting on the campaign and pending conference call, Mr. Reidy stated, "Much progress has been made that we look forward to sharing with our fellow shareholders, and we remain committed to our goals to effect the changes needed to unlock shareholder value and provide the level of transparency we have continued to advocate."

Tom Reidy, 816-260-8476, tjreidy3@hotmail.com


'/>"/>
SOURCE KC Investor Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Champions Biotechnology, Inc.s Doug Burkett, PhD, to Present at BIO CEO & Investor Conference
2. Genaera to Present at BIO CEO & Investor Conference
3. Rigel to Present at BIO CEO & Investor Conference
4. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIO CEO and Investor Conference in New York City
5. Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference
6. VirtualScopics to Present at 11th Annual BIO CEO & Investor Conference
7. ISTA Pharmaceuticals to Present at the 11th Annual BIO CEO & Investor Conference
8. Nile Therapeutics to Present at the 2009 BIO CEO & Investor Conference
9. SuperGen to Present at BIO CEO & Investor Conference on February 10, 2009
10. Haemacure to Present at the 11th Annual BIO CEO & Investor Conference
11. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: